CoQ10 is a key mitochondrial antioxidant, and circulating levels are often reduced in people with chronic kidney disease and chronic heart failure, where deficiency is linked to greater oxidative stress and poorer organ function. In CKD cohorts, lower CoQ10 levels correlate with increased cardiovascular risk, and supplementation has been reported to improve markers such as proteinuria, mitochondrial function, and oxidative stress, with some studies suggesting better preservation of kidney function over time. In patients with chronic heart failure, trials such as Q-SYMBIO have shown that CoQ10 supplementation can improve cardiac function parameters and significantly reduce major adverse cardiovascular events, cardiovascular mortality, and heart‑failure–related hospitalizations. This medication is commonly used for High Cholesterol.
Xu Y, Liu J, Han E, Wang Y, Gao J. Efficacy of coenzyme Q10 in patients with chronic kidney disease: protocol for a systematic review. BMJ Open. 2019 May 14;9(5):e029053. Bakhshayeshkaram M, Lankarani KB, Mirhosseini N, Tabrizi R, Akbari M, Dabbaghmanesh MH, Asemi Z. The Effects of Coenzyme Q10 Supplementation on Metabolic Profiles of Patients with Chronic Kidney Disease: A Systematic Review and Meta-analysis of Randomized Controlled Trials. Curr Pharm Des. 2018;24(31):3710-3723. Di Lorenzo A, Iannuzzo G, Parlato A, Cuomo G, Testa C, Coppola M, D'Ambrosio G, Oliviero DA, Sarullo S, Vitale G, Nugara C, Sarullo FM, Giallauria F. Clinical Evidence for Q10 Coenzyme Supplementation in Heart Failure: From Energetics to Functional Improvement. J Clin Med. 2020 Apr 27;9(5):1266. DiNicolantonio JJ, Bhutani J, McCarty MF, O'Keefe JH. Coenzyme Q10 for the treatment of heart failure: a review of the literature. Open Heart. 2015;2:e000326.
Some side effects may be linked to nutrient depletion caused by this medication.
While studies demonstrate statins effectively lower LDL-C and apoB, research suggests they may also reduce CoQ10 levels. This vital antioxidant plays a crucial role in mitochondrial function, and deficiency can impact brain, muscle, kidney, and heart health. CoQ10 supplementation could be a helpful way to mitigate a potential deficiency when taking a statin therapy.
Statins can lead to elevated liver enzymes, which may increase the risk of liver damage. Studies suggest that liver injury can be associated with statins and potent antioxidants like NAC with its anti-inflammatory action is associated with improved liver circulation, hepatoprotective, and therapeutic in liver conditions and disease.
Magnesium supplements and statin medications both inhibit the HMG-CoA and have complementary effects to reducing the production of cholesterol. Magnesium has functions that are crucial to cardiovascular and general health as a catalyst to 300 healthy reactions in the body and 100 in the heart. The association between Magnesium supplementation and statins is also able to offer some protection for painful myopathy as a side effect induced by statins, which may also boost patient compliance. According to research, patients who received the statin drug atorvastatin along with a magnesium treatment had significantly increased levels of serum magnesium, HDL (the good cholesterol), as well as significantly decreased levels of total cholesterol, LDL cholesterol, and triglycerides.
Research has found vitamin E supplementation significantly increased the antioxidative capacity of LDL, which was partially abolished by statin therapy. Supplementation with vitamin E should be considered for its antioxidant and anti-inflammatory properties that may help reduce the oxidation of LDL and help protect against cardiovascular diseases.
Statins can lead to elevated liver enzymes, which may increase the risk of liver damage. Studies suggest that liver injury can be associated with statins and potent antioxidants like alpha lipoic acid with its anti-inflammatory action is associated with improved liver circulation, hepatoprotective, and therapeutic in liver conditions and disease.
Statin therapy can lead to side effects such as statin-associated muscle symptoms (SAMS), rhabdomyolysis myopathy, and myalgia. Research has demonstrated vitamin D is associated with deficient and insufficient status in patients taking statin drug therapy. It has also found vitamin D to be successful in preventing muscle-related side effects like SAMS. Supplementation with vitamin D should be considered to avoid a potential deficiency and to help protect against muscle related side effects.